KOCH KEVIN
SEC insider (Form 3/4/5 filer). CIK 0001185829. President and CEO at Edgewise Therapeutics, Inc. (EWTX). 19 reported Form 4/5 transactions since Sep 2024; latest on Aug 12, 2026. Located in BOULDER, CO.
Companies KOCH KEVIN has filed insider reports for
- Edgewise Therapeutics, Inc. (EWTX): Director, Officer, President and CEO
KOCH KEVIN
CIK: 0001185829
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Edgewise Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (19 total)
- Aug 12, 2026EWTX
Edgewise Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
200K shares- - Aug 12, 2026EWTX
Edgewise Therapeutics, Inc.
ExerciseDirect21.9K shares- - Aug 12, 2026EWTX
Edgewise Therapeutics, Inc.
SaleDirect8.8K shares at avg. $43.64$383K - Aug 12, 2026EWTX
Edgewise Therapeutics, Inc.
SaleDirect8.3K shares at avg. $43.66$361K - Aug 12, 2026EWTX
Edgewise Therapeutics, Inc.
SaleDirect913 shares at avg. $44.33$40K - Aug 12, 2026EWTX
Edgewise Therapeutics, Inc.
AwardDirectRestricted Stock Units
100K shares- - Aug 12, 2026EWTX
Edgewise Therapeutics, Inc.
ExerciseDirect18K shares- - Aug 12, 2025EWTX
Edgewise Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
525K shares- - Aug 12, 2025EWTX
Edgewise Therapeutics, Inc.
ExerciseDirect18K shares- - Aug 12, 2025EWTX
Edgewise Therapeutics, Inc.
SaleDirect8K shares at avg. $13.39$107K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc. | Award Stock Option (Right to Buy) | 200,000 | - | - | Direct |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc. | Exercise | 21,875 | - | $0 | Direct |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc. | Sale | 8,782 | $43.64 | $383,254 | Direct |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc. | Sale | 8,276 | $43.66 | $361,315 | Direct |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc. | Sale | 913 | $44.33 | $40,473 | Direct |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc. | Award Restricted Stock Units | 100,000 | - | - | Direct |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc. | Exercise | 17,969 | - | $0 | Direct |
| Aug 12, 2025 | EWTX Edgewise Therapeutics, Inc. | Award Stock Option (Right to Buy) | 525,000 | - | - | Direct |
| Aug 12, 2025 | EWTX Edgewise Therapeutics, Inc. | Exercise | 17,968 | - | - | Direct |
| Aug 12, 2025 | EWTX Edgewise Therapeutics, Inc. | Sale | 7,972 | $13.39 | $106,764 | Direct |
1-10 of 19 transactions